by McDermott + Bull | Aug 16, 2024 | Aaron Griffin, Aaron Griffin Article, Article
Executive leader’s face a myriad of challenges in managing today’s dynamic workforce. Our Partners and Managing Directors in executive search and interim leaders interviewed 14 executive clients to uncover the major factors impacting one of the most common...
by McDermott + Bull | May 22, 2024 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus
Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
by McDermott + Bull | May 16, 2024 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
A few weeks ago, McDermott + Bull Interim Leaders and I hosted a small breakfast for C-Level executives in the life sciences sector. Simon Arkell, CEO and Co-Founder of Ryght AI, joined us as our keynote speaker to share his thoughts and insights on AI and its impact...
by McDermott + Bull | May 6, 2024 | Article, Chris Bull, Chris Bull Article
For many organizations, partnering with an executive search firm can feel a bit like trusting a stranger with the keys to your success. Partnering with a search firm should be built on a foundation of trust, respect, mutual understanding, and collaboration. In this...
by McDermott + Bull | Jan 4, 2024 | Article, Brandon Biegenzahn, Brandon Biegenzahn Article
As we reflect on the dynamic year of 2023 in the executive talent industry, it’s evident that the landscape was shaped by various economic and demographic shifts. It began with increasing interest rates to combat inflation, leading to what some analysts term a...
by McDermott + Bull | Nov 29, 2023 | Article, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
Recently, my colleague Mark McConnell and I hosted a breakfast meeting with around 40 local C-Suite executives within the life sciences sector. Paul LaViollette, Managing Partner and Chief Operating Officer of SV Health Investors, joined us from Boston to share his...
